- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: PD-1 inhibitor Gemcitabine Cisplatin
Total 8468 results
-
Second Affiliated Hospital of Soochow UniversityRecruitingAdvanced Refractory Solid TumorsChina
-
BioAtla, Inc.RecruitingUndifferentiated Pleomorphic Sarcoma | MyxofibrosarcomaUnited States, Hong Kong, Taiwan
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)RecruitingRefractory Melanoma | HLA-A2 Positive Cells PresentUnited States
-
Second Affiliated Hospital of Soochow UniversityNot yet recruitingCarcinoma, Non-Small-Cell Lung | Carcinoma BreastChina
-
Sun Yat-sen UniversityRecruitingLiver Diseases | Hepatocellular Carcinoma | Immunotherapy | Sintilimab | LenvatinibChina
-
Leap Therapeutics, Inc.CompletedCholangiocarcinoma | Bile Duct Cancer | Carcinoma of Intrahepatic and Extra-hepatic Biliary System | Carcinoma of GallbladderUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedCombination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Pancreatic CancerPancreatic CancerUnited States, Canada
-
Federation Francophone de Cancerologie DigestiveCompletedLiver Cancer | Gallbladder Cancer | Extrahepatic Bile Duct CancerFrance
-
PfizerTerminatedCarcinoma, Non-Small-Cell LungUnited States, Canada, Belgium, Italy, Spain, United Kingdom, Korea, Republic of, Netherlands, Poland, Portugal, Turkey, Taiwan, Germany, Hungary, Brazil, Hong Kong, Singapore, South Africa, China, Austria, Czech Republic, India, Is... and more
-
Cairo UniversityCompleted
-
Lahey ClinicWithdrawnTransitional Cell CarcinomaUnited States
-
Jounce Therapeutics, Inc.Completed
-
First Affiliated Hospital of Zhejiang UniversityUnknownProgressive Multifocal Leukoencephalopathy | AIDSChina
-
Sun Yat-sen UniversityRecruitingLiver Diseases | Hepatocellular Carcinoma | Immunotherapy | Camrelizumab | LenvatinibChina
-
The First Affiliated Hospital with Nanjing Medical...Recruiting
-
Beijing Tongren HospitalNot yet recruitingExtranodal NK/T-cell Lymphoma, Nasal Type
-
Osaka Medical Center for Cancer and Cardiovascular...CompletedPancreatic CancerJapan
-
Virginia Commonwealth UniversityNational Cancer Institute (NCI)CompletedSolid TumorUnited States
-
Memorial Sloan Kettering Cancer CenterMayo Clinic; Hartford HospitalActive, not recruitingUrothelial CarcinomaUnited States
-
Symphogen A/SActive, not recruitingSym024 Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor MalignanciesSolid Tumor | Metastatic CancerUnited States, Canada
-
Merck Sharp & Dohme LLCCompletedCarcinoma | Non-small Cell Lung Cancer
-
University Hospital BirminghamUnknown
-
Taiho Oncology, Inc.Quintiles, Inc.Completed
-
National Cancer Institute, NaplesUniversity of Alberta; University of Campania "Luigi Vanvitelli"; Princess Margaret... and other collaboratorsCompletedAdvanced Non-Small Cell Lung CancerItaly, Canada
-
Hoffmann-La RocheCompletedCarcinoma, Non-Small-Cell LungChina
-
King Faisal Specialist Hospital & Research CenterSuspended
-
West China HospitalNot yet recruitingNasopharyngeal CarcinomaChina
-
ARCAGY/ GINECO GROUPCompleted
-
Chuangzhen ChenRecruitingCervical Cancer | Neoadjuvant ChemotherapyChina
-
Huazhong University of Science and TechnologyCSPC Ouyi Pharmaceutical Co., Ltd.Unknown
-
Air Force Military Medical University, ChinaCompletedToxicity Due to Radiotherapy | Nasopharyngeal Squamous Cell CarcinomaChina
-
Shanghai Jiao Tong University School of MedicineRecruitingOral Squamous Cell Carcinoma | Anti-PD-1 | Neoadjvant Therapy | Anti-VEGFRChina
-
Sun Yat-sen UniversityGuangdong Provincial Hospital of Traditional Chinese Medicine; Guangdong Provincial...Active, not recruitingColorectal Cancer | Microsatellite Instability HighChina
-
SanofiCompletedNon-small Cell Lung Cancer Stage IVSpain, France, Germany, Italy, United Kingdom
-
Jiangsu HengRui Medicine Co., Ltd.Terminated
-
Shanghai Zhongshan HospitalRecruitingHepatocellular CarcinomaChina
-
Merck Sharp & Dohme LLCCompleted
-
BioAtla, Inc.RecruitingNon-Small-Cell Lung CancerUnited States, Hong Kong, Taiwan, Spain, Greece, Germany, Italy, Poland
-
University Hospital, BordeauxRecruitingMetastatic Renal Cell Carcinoma | Good or Only One Adverse Prognostic Factor Intermediate Risk Per IMDC ScoreFrance
-
Second Affiliated Hospital of Soochow UniversityNot yet recruiting
-
Chinese PLA General HospitalLinkDoc Technology (Beijing) Co. Ltd.UnknownAdvanced Solid TumorsChina
-
Cardiff UniversityCompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral CancerUnited Kingdom
-
Fudan UniversityRecruitingNasopharyngeal CarcinomaChina
-
Sir Run Run Shaw HospitalHangzhou Neoantigen Therapeutics Co., Ltd.RecruitingAdvanced Malignant Solid TumorChina
-
Nanfang Hospital, Southern Medical UniversityRecruiting
-
Sun Yat-sen UniversityJiangsu HengRui Medicine Co., Ltd.Recruiting
-
BioAtla, Inc.RecruitingMelanoma | Head and Neck Cancer | Non Small Cell Lung Cancer | Triple Negative Breast CancerUnited States, Hong Kong, Taiwan, Spain, Greece, Germany, Italy, Poland
-
AstraZenecaActive, not recruitingNon Small Cell Lung Carcinoma NSCLCDenmark, United Kingdom, United States, Poland, Brazil, India, Japan, Mexico, Peru, Russian Federation, Turkey, China, Malaysia, Hong Kong, Korea, Republic of, Chile, Israel, Ukraine, Portugal, Greece, Bulgaria, Philippines, Sweden, A... and more
-
AstraZenecaActive, not recruitingNon Small Cell Lung Carcinoma NSCLCPoland, Taiwan, Thailand, Vietnam, United States, Korea, Republic of, Hungary, Russian Federation, Turkey, China, Australia, Netherlands